Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Efficacy of Radiotherapy in Combination With Zoledronic Acid on Pain Relief in Bone Metastasis Patients With Gastrointestinal Tumors

NCT02784652 is registered in ClinicalTrials.gov with Severance Hospital as lead sponsor.

NCT NCT02784652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02784652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Efficacy of Radiotherapy in Combination With Zoledronic Acid on Pain Relief in Bone Metastasis Patients With Gastrointestinal Tumors
Lead sponsor
Severance Hospital
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2014
Completion date
February 28, 2017
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastasis, gastrointestinal cancer